Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanmenxia Sainuowei Pharmaceutical is a specialized manufacturer of chemical intermediates and active pharmaceutical ingredients (APIs) based in Sanmenxia, Henan Province, China. Established in 2004, the company has become a globally recognized leader in the production of guanidine salts, specifically high-purity Guanidine Hydrochloride and Guanidine Carbonate. These products serve as critical building blocks in the synthesis of various pharmaceuticals, including antiviral medications and sulfonamides, and are widely used in the purification of proteins and nucleic acids in life science research. The company operates large-scale manufacturing facilities that comply with international quality management standards, including ISO 9001. Sainuowei Pharmaceutical primarily focuses on the industrial-scale supply of high-quality chemical reagents to the global pharmaceutical and biotech industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanmenxia Sainuowei Pharmaceutical.